Rising Healthcare Expenditure Fuels Growth In The Gastroparesis Market Driver: A Major Catalyst in the Evolution of the Gastroparesis Market in 2025

What industry-specific factors are fueling the growth of the gastroparesis market?
Anticipated expansion in healthcare spending could fuel the growth of the gastroparesis market. The term 'healthcare expenditure' relates to the total resources allocated to health services, such as hospital costs, payments to medical professionals, nursing and dental care expenses, medication costs, and public health initiatives. Various elements contribute to the increase in healthcare expenditure, including an aging population, medical technology advancements, a higher prevalence of chronic diseases, and heightened consumer expectations for superior healthcare services. The gastroparesis market is benefiting from this boost in healthcare expenses through increased financial support for research and development, more diverse treatment options, and improved patient access to specialized health care services. To illustrate, a report issued by the UK-based Office for National Statistics in May 2023 indicated that between 2022 and 2023, the UK's healthcare spending surged by 5.6%, in contrast to a modest growth of 0.9% in 2022. Healthcare expenditure in the UK was approximately $317.63 billion (£292 billion) in 2023. Hence, the upswing in healthcare expenditure is stimulating the growth of the gastroparesis market.

Get Your Gastroparesis Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

What Is the projected market size and growth rate for the gastroparesis market?
The expansion of the gastroparesis market has been consistent in the past few years. The market worth is set to rise from $6.84 billion in 2024 to a projected $7.17 billion in 2025, signaling a compound annual growth rate (CAGR) of 4.9%. The visible growth during the historic period is due to various factors such as the growing elderly population, increasing incidence of diabetes, enhanced comprehension of gastrointestinal disorders, development of treatment protocols, and better awareness about gastroparesis.

In the coming years, robust growth is projected in the gastroparesis market size, with it ballooning to $8.82 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 5.3%. This anticipated growth in the forecast period is due to the creation of novel therapeutic options, broadening of personalized treatment methods, integration of digital health solutions, improvement in healthcare infrastructure, and a growing emphasis on early diagnosis. Major trend shifts within this forecast period include advancements in gastric electrical stimulation therapy, an increasing amount of research into stem cell therapy, increasing adoption of minimally invasive surgical interventions, a surge in the usage of wearable health monitoring devices, and a shift towards more patient-centric care models.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

What new trends are reshaping the gastroparesis market and its opportunities?
Leading firms in the gastroparesis market are introducing inventive devices to boost their market earnings. These treatment devices, designed as medical instruments or equipment, aim to control or soften the symptoms of gastroparesis, a disorder marked by a delayed emptying process of the stomach. An example of this is the launch of the Enterra Therapy by Enterra Medical Inc., a US-based medical device company, in 2022. The device uses an implanted neurostimulator to generate mild electrical pulses, providing potential relief for chronic symptoms of nausea and vomiting associated with gastroparesis. This therapy is targeted towards individuals aged between 18 and 70 who experience persistent, unmanageable nausea and vomiting due to gastroparesis, stemming from diabetic or idiopathic causes.

What major market segments define the scope and growth of the gastroparesis market?
The gastroparesis market covered in this report is segmented -

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies
2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types
3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:
1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications
2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets
3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes
4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

Which region dominates the gastroparesis market?
North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the gastroparesis industry growth?
Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

What Is Covered In The Gastroparesis Global Market Report?

• Market Size Forecast: Examine the gastroparesis market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the gastroparesis market for a structured understanding.
• Key Players Overview: Analyze major players in the gastroparesis market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gastroparesis market.
• Segment Contributions: Evaluate how different segments drive overall growth in the gastroparesis market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gastroparesis market.
• Industry Challenges: Identify potential risks and obstacles affecting the gastroparesis market.
• Competitive Landscape: Review strategic developments in the gastroparesis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.